A Randomized Trial Examining the Effectiveness of Mobile-Based Asthma Action Plans vs. Paper Asthma Action Plans

Completed · Not applicable

Conditions studied: Asthma

In brief

The purpose of this study is to see if using a mobile phone application asthma action plan will help improve asthma management.

Key facts

Study ID

NCT02091869

Run by

Arkansas Children's Hospital Research Institute

People needed

34

Starts

2014-03-01

Expected to finish

2015-04-01

Last updated by the study team

2018-06-29

Who can join

Age: 12 and older, up to 17. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age ≥ 12 and ≤ 17 years.
• Access to Apple or Android based smart phone
• Mild to severe persistent asthma or poorly controlled asthma (see definitions below).
• o A different assessment of eligibility will be performed depending on whether or not the parent reports use of a preventive asthma medication at baseline. This is consistent with 2007 National Asthma Education Prevention Program recommendations that make a strong distinction between classifying asthma severity (for children not using preventive medications) and assessing control (for children using preventive medications). If a child has used a preventive medication in the past, but reports no use of the medication in the prior 3 months, we will assess severity.)
• Children not using a preventive medication at baseline: Assess for mild persistent to severe persistent asthma. Any 1 of the following, during the prior 4 weeks (as defined by parent interview in the waiting room) will determine severity:
• An average of >2 days per week with asthma symptoms
• >2 days per week with rescue medication use
• ≥2 nights per month awakened with nighttime symptoms
• Minor limitation of activity
• ≥2 episodes of asthma during the past year that have required systemic corticosteroids
• Children using a preventive medication at baseline: Assess for poorly controlled asthma. Any 1 of the following, during the prior 4 weeks (as defined by parent interview in the waiting room) will determine control:
• An average of >2 days per week with asthma symptoms
• >2 days per week with rescue medication use
• ≥2 nights per month awakened with nighttime symptoms
• Some limitation of activity
• ≥2 episodes of asthma during the past year that have required systemic corticosteroids.

You may not qualify if…

• Significant underlying respiratory disease other than asthma (such as cystic fibrosis or chronic lung disease) that could potentially interfere with asthma-related outcome measures.
• Significant co-morbid conditions (such as moderate to severe developmental delay, i.e. special education classroom or diagnosis) that could preclude participation in an education-based intervention.
• Inability to speak or understand English (child or parent).
• Children in foster care or other situations in which consent cannot be obtained from a guardian.
• Prior enrollment in the study.

Where it is running

• Arkansas Children's Hospital Research Institute — Little Rock, Arkansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.